Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.77 Analyst target: $2.00 Upside: 160.38%
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures and markets solutions for the advanced wound care and surgical and sports medicine markets in the United States. The company is headquartered in Canton, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.